Sentences with phrase «in pharmaceutical compounds»

Not exact matches

Founded in 2010, Vet's First Choice provides FDA - and EPA - approved pharmaceuticals, therapeutic diets, and compounded medications to pet owners on behalf of veterinary practices.

The global market for pharmaceutical contract manufacturing, contract research and contract packaging will grow from $ 136.4 billion in 2017 to $ 197.0 billion by 2022 with a compound annual growth rate (CAGR) of 7.6 % for the period of 2017 - 2022.

«We need further studies to help us apply this knowledge to health in humans potentially through tailored diets favoring certain tastes or even pharmaceutical compounds that target taste inputs without diet alterations.»

In addition to the performance of studies we also advise many pharmaceutical companies about the early development of their new compounds.

In contrast, preparation of more elaborate phosphorus compounds used in chemical catalysis, pharmaceutical, and battery applications requires laborious generation and chlorination of elemental phosphoruIn contrast, preparation of more elaborate phosphorus compounds used in chemical catalysis, pharmaceutical, and battery applications requires laborious generation and chlorination of elemental phosphoruin chemical catalysis, pharmaceutical, and battery applications requires laborious generation and chlorination of elemental phosphorus.

The university was looking for a pharmaceutical scientist to evaluate antimalarial compounds synthesized in the lab.

In some cases these research opportunities arose from a joint venture between BPRU and a pharmaceutical company in the interest of furthering research, such as testing the abuse liability of a novel compounIn some cases these research opportunities arose from a joint venture between BPRU and a pharmaceutical company in the interest of furthering research, such as testing the abuse liability of a novel compounin the interest of furthering research, such as testing the abuse liability of a novel compound.

The novel technique may be useful for making compounds important in agriculture and pharmaceuticals with less damage to the environment.

They focused on reactions that create alkoxysilanes — a common ingredient in ceramics and in organic compounds used in agriculture and pharmaceuticals.

So, if you are a chemist and like simulations — why not try using your knowledge and working in a young start - up, developing tools which will be used for «intelligent» discovery of new pharmaceutical compounds?

Kelly M. Standifer, professor and chair of pharmaceutical sciences at the University of Oklahoma, points out that the researchers tested the compounds» potency in nonneuronal cells forced to express the receptors.

A specially designed chiral catalyst is used to oxidize hydrocarbons into multifunctional compounds that are obtained in high purity and are readily converted into an assortment of molecules that will streamline the synthesis of future pharmaceutical drugs,» said Dr. Leila Bayeh, a former graduate student and lead author of the study.

Deuterium - and tritium - labeled pharmaceutical compounds are pivotal diagnostic tools in drug discovery research, providing vital information about the biological fate of drugs and drug metabolites.

The system also will allow scientists to test millions of compounds in the environment and new pharmaceuticals to understand how they affect the reproductive system and many other organs in the body.

In future, it will be much easier to produce some active pharmaceutical substances and chemical compounds than was the case to date.

Typically, pharmaceutical scientists start the discovery process by «screening» large libraries of chemical compounds in search of one or a few that might treat disease.

Palladium catalysts are used to form an array of chemical compounds in pharmaceuticals, plastics, agrochemicals, and many other industries.

Their results confirmed that wastewater plants are important sources of pharmaceuticals, but they also demonstrated that these compounds are common in streams that aren't fed by wastewater plants.

Cyclodextrin is a sugar molecule that long has been used as a minor ingredient in many other pharmaceuticals because it helps drug compounds dissolve in water.

But this also provides ample time for chlorine to interact with pharmaceuticals that may be in the water, encouraging development of new antibiotic compounds.

«This finding opens up for new possibilities to stabilise the vast number of amorphous compounds in the R&D pipe - line of big pharmaceutical companies», says Maria Strömme, Professor of Nanotechnology at Uppsala University.

«We have identified a number of pharmaceutical compounds that selectively inhibit — in different experimental models — the mitochondrial enzyme responsible for the tumour growth, thus limiting fat synthesis and without harming normal cells.»

For example, the best national pharmaceutical companies are starting to invest in the validation of plant - derived medicines in an attempt to lay claim to new medicines and compete with the conventional imported compounds, which make up over 70 % of the Brazilian market.

Eng's 1996 conference presentation on a compound in Gila monster venom that affects insulin production caught the attention of biotechnology company Amylin Pharmaceuticals.

specialising in environmental technology, pharmaceutical residues, their variants and other similar compounds degrade easily from wastewater because the process is non-selective.

The same selective process should also be applied to the recovery of high - value compounds in a chemical or pharmaceutical production plant, where they might otherwise be wasted, Su says.

Those were developed, in part, as a byproduct of previous alliances in which pharmaceutical companies payed for rights to develop would - be drugs discovered at Scripps, as well as through the more traditional approach of licensing early - stage compounds to startup companies that then raise money to develop them further.

There is considerable uncertainty surrounding emerging contaminants in aquatic ecosystems and groundwater, and a recent Penn State study of compounds from pharmaceuticals and personal care products didn't add much clarity.

However, crops that contain pharmaceutical and industrial compounds, many of which are in field trials, do raise concern, says Norman Ellstrand of the University of California, Riverside.

It is generally thought that these compounds have reached the aquatic environment for as long as they have been commercially used, but only during the last decade or so has environmental research been widely conducted and concerns over the effects of pharmaceuticals in water bodies been raised.

Chemists at The University of Texas at Arlington have devised a safer, more environmentally friendly, less expensive and more efficient water - based system for the synthesis of organic compounds typically used in pharmaceuticals, agrochemicals, cosmetics, plastics, textiles and household chemicals.

Researchers in the Doyle lab at Princeton have developed a direct cross-coupling reaction to produce nitrogen - containing compounds called 1,2 - dihydropyridines, versatile building blocks that are highly useful in pharmaceutical research.

Drug companies have shown an increasing interest in incorporating CF3 compounds — which contain carbon and fluorine — in a range of pharmaceuticals.

That's part of the reason that most drugs that work in animals don't work in people — only 11 % of oncology compounds that show promise in mice are ever approved for humans — despite billions of dollars spent by pharmaceutical and biotech companies.

It identifies and quantifies the various compounds present in a pharmaceutical product, in a fifth of the time it takes governmental services to do the same job.

PBPK modeling is used in pharmaceutical research and development and in health risk assessment to predict the absorption, distribution, metabolism and excretion of a compound in humans and other animal species.

We established formal partnerships with major pharmaceutical and biotechnology companies to develop compounds or identify targets that enhance interneuron function or restore brain rhythms in models of AD and epilepsy.

This investigation also determines the feasibility of developing improved pharmaceuticals in microgravity using a new method to test the metabolic impacts of drug compounds.

These risks and uncertainties include, among others, those relating to our ability to obtain financing and to form collaborative relationships, uncertainty regarding potential future deterioration in the market for auction rate securities which could result in additional permanent impairment charges, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

Clementia Pharmaceuticals licensed palovarotene from Roche Pharmaceuticals, which previously investigated the compound as a possible treatment for chronic pulmonary disease and evaluated its safety in more than 800 healthy volunteers and patients.

He and his team, in collaboration with pharmaceutical company AstraZeneca, are currently using the new peptides to discover Gαq - blocking compounds that might be developed into treatments for this form of cancer.

Cells have become essential in modern medicine as therapies, vehicles for producing high ‑ value therapeutics, and tools for high ‑ throughput screening of pharmaceutical compounds.

In recent years, the lab has actively collaborated with pharmaceutical companies to obtain compounds in early stages of preclinical and clinical developmenIn recent years, the lab has actively collaborated with pharmaceutical companies to obtain compounds in early stages of preclinical and clinical developmenin early stages of preclinical and clinical development.

These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

A collaboration with the Roche pharmaceutical company led to the screening of 200 000 Roche compounds on human neural stem cells in order to identify proliferative drugs.

However, with few exceptions, the stem cell and regenerative medicine industry has remained inadequately capitalized to carry out large - scale clinical trials independently, and major pharmaceutical firms have tended to show more interest in the use of hiPSCs as a source of large, pure populations of specific somatic cells for use in drug compound screening and toxicology tests, than they have in therapeutic uses of stem cells and their derivatives.

These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, the outcome of the review of the continued listing of our common stock on The Nasdaq Stock Market, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

Ultimately, two of the identified genes led to compounds being studied in drug development projects with pharmaceutical partners.

«It's one thing to only try to correct splicing events, but there are a lot more opportunities in terms of drug targets,» says Gideon Dreyfuss, a biochemist at the University of Pennsylvania Perelman School of Medicine in Philadelphia who is working with the New Jersey — based pharmaceutical firm Merck to discover new compounds.

In ensuing experiments, Dr. Ding hopes to rely only on microRNAs and pharmaceutical compounds to convert skin cells to brain cells, which should lead to more efficient generation of cells for testing and regenerative purposes.